Annals of the New York Academy of Sciences logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 1248, Number 1, 1 February 2012

< previous issue | all issues | next issue >

The clinical significance of drug craving
pp. 1-17(17)
Authors: Tiffany, Stephen T.; Wray, Jennifer M.

Designer drugs: a medicinal chemistry perspective
pp. 18-38(21)
Authors: Carroll, F. Ivy; Lewin, Anita H.; Mascarella, S. Wayne; Seltzman, Herbert H.; Reddy, P. Anantha

Mouse models for studying genetic influences on factors determining smoking cessation success in humans
pp. 39-70(32)
Authors: Hall, F. Scott; Markou, Athina; Levin, Edward D.; Uhl, George R.

Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system
pp. 71-88(18)
Authors: Morales, Marisela; Pickel, Virginia M.

A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
pp. 89-106(18)
Authors: Wing, Victoria C.; Wass, Caroline E.; Soh, Debra W.; George, Tony P.

Socioeconomic status and smoking: a review
pp. 107-123(17)
Authors: Hiscock, Rosemary; Bauld, Linda; Amos, Amanda; Fidler, Jennifer A.; Munafò, Marcus

The history of the development of buprenorphine as an addiction therapeutic
pp. 124-139(16)
Authors: Campbell, Nancy D.; Lovell, Anne M.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page